Amyloid-β Peptides Interact with Plasma Proteins and Erythrocytes: Implications for Their Quantitation in Plasma

This publication has 41 references indexed in Scilit:

• Plasma amyloid ?-peptide 1-42 and incipient Alzheimer's disease
  Annals of Neurology, 1999
• Lipoprotein-free amyloidogenic peptides in plasma are elevated in patients with sporadic Alzheimer's disease and Down's syndrome
  Annals of Neurology, 1999
• Increased plasma amyloid β protein 1–42 levels in Down syndrome
  Neuroscience Letters, 1998
• Alzheimer's soluble amyloid β is a normal component of human urine
  FEBS Letters, 1997
• Analysis of Heterogeneous βA4 Peptides in Human Cerebrospinal Fluid and Blood by a Newly Developed Sensitive Western Blot Assay
  Journal of Biological Chemistry, 1996
• Secreted amyloid β–protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease
  Nature Medicine, 1996
• Isolation and quantification of soluble Alzheimer's β-peptide from biological fluids
  Nature, 1992
• Localization of Alzheimer βA4 amyloid precursor protein at central and peripheral synaptic sites
  Brain Research, 1991
• Expression of β amyloid protein precursor mRNAs: Recognition of a novel alternatively spliced form and quantitation in alzheimer's disease using PCR
  Neuron, 1990
• Amyloid β-protein deposition in tissues other than brain in Alzheimer's disease
  Nature, 1989